Evidence map›Paper›PMID 19948765›Full record

ArticleRNA (New York, N.Y.)2010

A structural analysis of the group II intron active site and implications for the spliceosome.

Kevin S Keating, Navtej Toor, Philip S Perlman, Anna Marie Pyle

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. The ChloroplastCells · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Topology of the U12-U6ACS omega · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RNA ligation precedes the retrotransposition of U6/LINE-1 chimeric RNA.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Human METTL16 is aEMBO reports · 2017
    Article
  19. Evolution of intrinsic disorder in eukaryotic proteins.Cellular and molecular life sciences : CMLS · 2017
    Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin S KeatingProgram in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06520, USA.
Navtej Toor
Philip S Perlman
Anna Marie Pyle
Howard Hughes Medical Institute · USYale University · US

Funding

STUCTURE AND FUNCTION OF GROUP II INTRONSR01GM050313 · NIGMS · YALE UNIVERSITY · PI PYLE, ANNA MARIE · 1994 to 2016
$4.6M
Howard Hughes Medical InstituteNIGMS NIH HHS GM R0150313
6 · The paper itself

Abstract

Group II introns are self-splicing, mobile genetic elements that have fundamentally influenced the organization of terrestrial genomes. These large ribozymes remain important for gene expression in almost all forms of bacteria and eukaryotes and they are believed to share a common ancestry with the eukaryotic spliceosome that is required for processing all nuclear pre-mRNAs. The three-dimensional structure of a group IIC intron was recently determined by X-ray crystallography, making it possible to visualize the active site and the elaborate network of tertiary interactions that stabilize the molecule. Here we describe the molecular features of the active site in detail and evaluate their correspondence with prior biochemical, genetic, and phylogenetic analyses on group II introns. In addition, we evaluate the structural significance of RNA motifs within the intron core, such as the major-groove triple helix and the domain 5 bulge. Having combined what is known about the group II intron core, we then compare it with known structural features of U6 snRNA in the eukaryotic spliceosome. This analysis leads to a set of predictions for the molecular structure of the spliceosomal active site.

Indexed as

Nucleic Acid ConformationAlternative SplicingBase SequenceCatalytic DomainCrystallography, X-RayEukaryotic CellsIntronsModels, BiologicalModels, MolecularMolecular Sequence DataRNA, CatalyticRNA Splice SitesSpliceosomesStructure-Activity RelationshipRNA, CatalyticRNA Splice Sites

Identifiers

PMID19948765
PMCPMC2802019
OpenAlexW2139966953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.